Tecfidera 240 mg Norvegija - norvegų - Statens legemiddelverk

tecfidera 240 mg

2care4 aps - dimetylfumarat - enterokapsel, hard - 240 mg

Tecfidera 240 mg Norvegija - norvegų - Statens legemiddelverk

tecfidera 240 mg

orifarm as - dimetylfumarat - enterokapsel, hard - 240 mg

Tecfidera 120 mg Norvegija - norvegų - Statens legemiddelverk

tecfidera 120 mg

orifarm as - dimetylfumarat - enterokapsel, hard - 120 mg

Tecfidera Europos Sąjunga - norvegų - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dimetylfumarat - multippel sklerose - immunsuppressive - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Skilarence Europos Sąjunga - norvegų - EMA (European Medicines Agency)

skilarence

almirall s.a - dimetylfumarat - psoriasis - immunsuppressive - skilarens er indisert for behandling av moderat til alvorlig plakspsoriasis hos voksne som har behov for systemisk medisinsk terapi.

Dimethyl fumarate Mylan Europos Sąjunga - norvegų - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Europos Sąjunga - norvegų - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Europos Sąjunga - norvegų - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Europos Sąjunga - norvegų - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Cardalis Europos Sąjunga - norvegų - EMA (European Medicines Agency)

cardalis

ceva santé animale - benazepril hydrochloride, spironolactone - hjerte-og karsystemet - hunder - for behandling av kongestiv hjertesvikt forårsaket av kronisk degenerativ valvulær sykdom hos hunder (med diuretisk støtte etter behov).